Real-world Outcomes Following Biologic Initiation in US Patients with Chronic Rhinosinusitis with Nasal Polyps Article

sustainable development goals

publication date

  • February 19, 2025

webpage

published in

keywords

  • Allergist/immunologist
  • Biologics
  • Chronic rhinosinusitis with nasal polyposis (CRSwNP)
  • Dupilumab
  • Ear-nose-throat
  • Mepolizumab
  • Omalizumab
  • Otolaryngologist
  • Real-world data